We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M Turnover 57.14%
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.62%
5 Year Est. Return
+129.91%
10 Year Est. Return
+554.84%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK icon
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.03T
$524M 2.18%
22,540,900
+576,300
+3% +$12.3M
2013 Q2
4 quarters
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.42T
$369M 1.54%
12,784,785
+364,886
+3% +$9.9M
2013 Q2
4 quarters
PFE icon
3
Pfizer
PFE
$174B
$338M 1.41%
12,006,168
+9,927
+0.1% +$283K
2013 Q2
4 quarters
AMGN icon
4
Amgen
AMGN
$252B
$333M 1.39%
2,816,064
-35,875
-1% -$4.15M
2013 Q2
4 quarters
GILD icon
5
Gilead Sciences
GILD
$212B
$329M 1.37%
3,966,623
+1,463,021
+58% +$114M
2013 Q2
4 quarters
XOM icon
6
ExxonMobil
XOM
$770B
$319M 1.33%
3,172,345
+154,273
+5% +$15.6M
2013 Q2
4 quarters
ORCL icon
7
Oracle
ORCL
$396B
$302M 1.26%
7,443,305
-279,613
-4% -$11.5M
2013 Q2
4 quarters
WFC icon
8
Wells Fargo
WFC
$250B
$296M 1.23%
5,637,418
-384,587
-6% -$19.3M
2013 Q2
4 quarters
MSFT icon
9
Microsoft
MSFT
$3.88T
$264M 1.1%
6,341,551
+422,880
+7% +$17.1M
2013 Q2
4 quarters
JNJ icon
10
Johnson & Johnson
JNJ
$658B
$220M 0.92%
2,107,062
-67,860
-3% -$6.86M
2013 Q2
4 quarters
MRK icon
11
Merck
MRK
$369B
$220M 0.92%
3,985,132
+236,228
+6% +$12.9M
2013 Q2
4 quarters
COP icon
12
ConocoPhillips
COP
$185B
$210M 0.87%
2,448,220
+56,432
+2% +$4.4M
2013 Q2
4 quarters
HPQ icon
13
HP
HPQ
$26B
$208M 0.86%
13,583,107
-723,705
-5% -$10.9M
2013 Q2
4 quarters
UNH icon
14
UnitedHealth
UNH
$365B
$198M 0.83%
2,426,760
+72,876
+3% +$5.73M
2013 Q2
4 quarters
CNH icon
15
CNH Industrial
CNH
$18.9B
$195M 0.81%
21,881,428
+970,651
+5% +$9.26M
2013 Q4
2 quarters
CVX icon
16
Chevron
CVX
$462B
$191M 0.8%
1,465,637
+38,397
+3% +$4.78M
2013 Q2
4 quarters
DB icon
17
Deutsche Bank
DB
$62.4B
$189M 0.79%
5,990,331
-6,935,415
-54% -$247M
2013 Q2
4 quarters
VZ icon
18
Verizon
VZ
$185B
$188M 0.78%
3,851,832
-3,833,893
-50% -$186M
2013 Q2
4 quarters
DFS icon
19
DELISTED
Discover Financial Services
DFS
$182M 0.76%
2,932,626
+20,542
+0.7% +$1.2M
2013 Q2
4 quarters
MRO icon
20
DELISTED
Marathon Oil Corporation
MRO
$181M 0.75%
4,541,183
-94,672
-2% -$3.49M
2013 Q2
4 quarters
NOC icon
21
Northrop Grumman
NOC
$79.2B
$181M 0.75%
1,508,940
+13,840
+0.9% +$1.67M
2013 Q2
4 quarters
CMCSA icon
22
Comcast
CMCSA
$82.5B
$177M 0.74%
6,590,186
-3,127,532
-32% -$80.4M
2013 Q2
4 quarters
BKNG icon
23
Booking.com
BKNG
$111B
$173M 0.72%
3,589,900
+21,025
+0.6% +$1.01M
2013 Q2
4 quarters
NSC icon
24
Norfolk Southern
NSC
$77B
$172M 0.71%
1,667,646
-44,620
-3% -$4.38M
2013 Q2
4 quarters
RTN
25
DELISTED
Raytheon Company
RTN
$171M 0.71%
1,857,676
+59,430
+3% +$5.76M
2013 Q2
4 quarters
1
2 3 4 5

Similar funds

Ventas Inc
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
Forefront Analytics
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
Point Break Capital Management
Point Break Capital Management Miami, Florida $91.7M AUM
Crystal Cove Asset Management
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
Atlas Wealth Partners
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
Significant Wealth Partners
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
Sunstone Asset Management
Sunstone Asset Management New York $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.